United Kingdom · Question · Written question
HL HL6784
Semaglutide: Artificial Intelligence
Introduced
23 April 2025
Last action
30 April 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Artificial intelligence
Source updated
30 April 2025
Summary
To ask His Majesty's Government what assessment they have made of the (1) benefits and (2) risks of using wearable technology and AI-driven monitoring systems to track vital signs in patients who are prescribed semaglutide; and whether those systems could
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
23 April 2025
Written question
To ask His Majesty's Government what assessment they have made of the (1) benefits and (2) risks of using wearable technology and AI-driven monitoring systems to track vital signs in patients who are prescribed semaglutide; and whether those systems could
Source: Lords
30 April 2025
Answer
The National Institute for Health and Care Excellence has published early value assessment guidance on digital technologies for delivering multidisciplinary weight management services. This includes recommendations on which technologies can be used in the...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-04-23/HL6784
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1796541
- uk · wq-1796541 · source updated 30 April 2025